Skip to main content

Table 1 Literature review of cervical and anorectal cancer

From: Laparoscopic ovarian transposition before pelvic radiation in rectal cancer patient: safety and feasibility

Reference Number Treatment Proportion of patients with preserved ovarian function Follow-up (Months)
Leonard A Farber [3] 1 Radiotherapy + LOT+LAR 100% 13
Hodel et al. [7] 9 RH+LOT±XRT 78% Ns
Husseinzadeh et al. [8] 22 RH+LOT 100% Ns
14 LOT+XRT 67%
4 RH+LOT+XRT 50%
Chambers et al. [9] 54 RH 96% 54(median)
25 RH+LOT 96% 36(median)
Chambers et al. [10] 14 RH+LOT+ Radiotherapy 71% 35(median)
Feeney et al. [11] 58 RH+BSO±XRT 0% 24(mean)
104 RH+LOT 97%
28 RH+LOT+XRT 50%
Covens et al. [12] 3 PLND+LOT+XRT 66% 25-32
Van Eijkeren et al. [13] 36 RH+LOT 95% 36-48
18 RH+LOT+XRT 72%
Morice et al. [14] 11 RH+LOT 100% 31(median)
59 RH+LOT+Brachy 90%
35 RH+LOT+XRT+Brachy 60%
Yamamoto et al. [15] 30 RH+LOT 97/89% At 12 v.s. At 60
26 RH+LOT+XRT 65/39%
Buekers et al. [16] 17 Radiotherapy + LOT ±RH 41% At 12
Treissman MJ et al. [17] 1 Radiotherapy +LOT 50% 8
  1. RH radical hysterectomy, LOT lateral ovarian transposition, XRT external beam radiotherapy, BSO bilateral salpingo-oophorectomy, PLND pelvic lymph node dissection only, Brachy brachytherapy, Ns not stated.